| View |
|
DR-XY 49016
|
Bupivacaine hydrochloride
|
Porsvacaine
|
5 mg/mL (0.5% w/v)
|
Solution for Injection (Epidural, Intraarticular, Subcutaneous or Perineural)
|
Local Anesthetic (Amide)
|
Med Biopharm Pvt. Ltd.
|
India
|
Initial
|
08 March 2024
|
08 March 2029
|
| View |
|
DRP-14972
|
Prasugrel (as Hydrochloride)
|
Prasu
|
10 mg
|
Film-Coated Tablet
|
Antithrombotic
|
Towa Pharma Private Limited
|
India
|
Initial
|
06 March 2024
|
06 March 2029
|
| View |
|
DRP-15003
|
Mesna
|
Melnna
|
100 mg/mL (400 mg/ 4 mL)
|
Solution for Injection
|
Detoxifying Agent for Antineoplastic Treatment
|
Getwell Pharmaceuticals
|
India
|
Initial
|
07 March 2024
|
07 March 2029
|
| View |
|
DRP-15002
|
Mesna
|
Melnna
|
100 mg/mL (200 mg/ 2 mL)
|
Solution for Injection
|
Detoxifying Agent for Antineoplastic Treatment
|
Getwell Pharmaceuticals
|
India
|
Initial
|
07 March 2024
|
07 March 2029
|
| View |
|
BR-088
|
Enoxaparin Sodium
|
Hepaclex
|
60 mg/0.6 mL
|
Solution for Injection (SC)
|
Antithrombotic Agents
|
Gland Pharma Limited
|
India
|
Renewal
|
07 March 2024
|
04 June 2028
|
| View |
|
DRP-15004
|
Meropenem (as trihydrate)
|
Emapen
|
1 g
|
Powder for Solution for Injection (I.V.)
|
Carbapenem
|
Maxitech Pharma (Pvt) Ltd.
|
Pakistan
|
Initial
|
07 March 2024
|
07 March 2029
|
| View |
|
DRP-14808
|
Levocarnitine
|
Levocarnil
|
200 mg/mL (1 g/5 mL)
|
Solution for Injection (IV)
|
Amino acids and derivatives
|
Farbe Firma Pvt. Ltd.
|
India
|
Initial
|
06 March 2024
|
06 March 2029
|
| View |
|
DR-XY47437
|
Co-Amoxiclav
|
None
|
156.25mg/5 mL
|
Powder for suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial (Correction)
|
06 March 2024
|
30 September 2026
|
| View |
|
DR-XY48999
|
Valganciclovir (as hydrochloride)
|
VagaCyte
|
450 mg
|
Film-Coated Tablet
|
Antiviral
|
Panacea Biotec Ltd.
|
India
|
Initial
|
11 March 2024
|
11 March 2029
|
| View |
|
DR-XY49018
|
Ascorbic Acid + dl-Alpha Tocopheryl Acetate pha Tocopheryl Acetate (Vitamin E)
|
None
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 12 mg
|
Capsule
|
Vitamins
|
Aldrtz Corporation
|
Philippines
|
Initial
|
12 March 2024
|
12 March 2026
|
| View |
|
DRP-15008
|
Paracetamol + Guaifenesin Phenylephrine.
hydrochloride + Dextromethorphan hydrobromide + Chlorpheniramine maleate
|
None
|
250 mg/100 mg/10 mg/10 mg/1 mg
|
Tablet
|
Antipyretic/Analgesic/Expectorant/Nasal
Decongestant/Antitussive/Antihistamine
|
La Croesus Pharma, Inc.
|
Philippines
|
Initial
|
11 March 2024
|
11 March 2029
|
| View |
|
DRHR-2350
|
Methyl Salicylate + Camphor + Menthol
|
Katinko Calming
|
10 mg / 5 mg per mL
|
Liniment (Lavender Scent)
|
Counterirritant
|
Greenstone Pharmaceutical, Inc.
|
Philippines
|
Initial
|
12 March 2024
|
12 March 2029
|
| View |
|
DRP-15010
|
Ascorbic Acid + Zinc
|
None
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10 mg (equivalent to 31.11 mg Zinc Citrate)
|
Capsule
|
Vitamin / Mineral
|
Pascual Laboratories, Inc.
|
Philippines
|
Initial
|
12 March 2024
|
12 March 2026
|
| View |
|
DRP-15009
|
Cetrorelix (as acetate)
|
Cetrostal
|
250 mcg/500mcL
|
Solution for Injection (SC)
|
Anti-Gonadotropin-Releasing Hormone
|
Memphis Vision Care Pvt. Ltd.
|
India
|
Initial
|
12 March 2024
|
11 March 2029
|
| View |
|
DRP-14971
|
Amoxicillin (as trihydrate)
|
Ambimox
|
500 mg
|
Capsule
|
Antibacterial
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
29 February 2024
|
01 March 2029
|
| View |
|
DRP-9393
|
Multivitamins + Iron
|
None
|
Each capsule contains: Iron (equivalent to 200 mg Ferrous Sulfate)-65 mg Pyridoxine HCI (Vitamin B6)-2.44mg Ascorbic Acid (Vitamin C)-120mg Riboflavin (Vitamin B2)-2.40mg Niacinamide (Vitamin B3)-20mg Folic Acid-440 mcg Thiamine HCI (Vitamin B1)-2.68mg Cyanocobalamin (Vitamin B12)-12mcg
|
Capsule
|
Vitamins / Mineral
|
Vonwelt, Inc.
|
|
Automatic Renewal (OTC)
|
27 April 2021
|
02 July 2026
|
| View |
|
DR-XY49019
|
Rivaroxaban
|
Rivaxored
|
10 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Dr. Reddy's Laboratories Limited (FTO Unit 2)
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DR-XY49020
|
Rivaroxaban
|
Rivaxored
|
15 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Dr. Reddy's Laboratories Limited (FTO - Unit 2)
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DR-XY49021
|
Rivaroxaban
|
Rivaxored
|
20 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct factor Xa inhibitor)
|
Dr. Reddy's Laboratories Limited (FTO - Unit 2)
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DRP-15011
|
Metfromin Hydrochloride
|
None
|
500 mg
|
Extended-Released Tablet
|
Oral Hypoglycemic Agent
|
Bafna Pharmaceuticals Limited
|
India
|
Initial
|
13 March 2024
|
13 March 2026
|